 When you have a standard where you hit a threshold of people who have serious negative side effects and a drug is to be pulled from the market, and you allow Moderna and Pfizer, and in this case over in the European market, AstraZeneca, blow right by those usual standards and infect more people with these negative side effects, and you don't do anything about it, that becomes an issue.